Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease-free survival among patients with recurrent esophageal cancer

Journal of Surgical Oncology

Volumn 87, Issue 1, 2004, Pages 26-31

  Motoyama, Satoru ^a   Okuyama, Manabu ^a   Kitamura, Michihiko ^b   Saito, Reijiro ^a   Kamata, Shuichi ^a   Murata, Katsuyuki ^a   Ogawa, Jun Ichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Iwate Prefectural Isawa Hospital   (Japan)

Author keywords

Autologous blood transfusion; Recurrence; Thoracic esophageal cancer

Indexed keywords

ADULT; AGED; ALLOGENEIC BLOOD TRANSFUSION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CANCER PATIENT; CANCER SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; BLOOD TRANSFUSION, AUTOLOGOUS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3042853923     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20064     Document Type: Article

References (28)

1. Blajchman MA: Immunomodulation and blood transfusion. Am J Ther 2002;9:389-395.
2. Vamvakas EC, Blajchman MA: Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction? Blood 2001;97:1180-1195.
3. Opelz G, Sengar DP, Mickey MR, et al.: Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5:253-259.
4. Heiss MN, Mempel W, Delanoff C, et al.: Blood transfusion-modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-1867.
5. Brand A, Houbiers JGA: Clinical studies of blood transfusion and cancer. In: Vamvakas EC, Blajchman MA, editors. Immunomodulatory effects of blood transfusion. Bethesda: AABB Press; 1999. pp 145-190.
6. Craig SR, Adam DJ, Yap PL, et al.: Effect of blood transfusion on survival after esophagogastrectomy for carcinoma. Ann Thorac Surg 1998;66:356-361.
7. Tachibana M, Tabara H, Kotoh T, et al.: Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. Am J Gastroenterol 1999;94:757-765.
8. Fong Y, Karpeh M, Mayer K, et al.: Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994;167:256-260.
9. Busch OR, Hop WC, Hoynck van Papendrecht MA, et al.: Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-1376.
10. Busch OR, Hop WC, Marquet RL, et al.: Blood transfusions and local tumor recurrence in colorectal cancer. Ann Surg 1994;220:791-797.
11. McAlister FA, Clark HD, Wells PS, et al.: Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: A metaanalysis of unconfounded studies. Br J Surg 1998;85:171-178.
12. Vamvakas E: Transfusion-associated cancer recurrence and infection: Meta-analysis of the randomized controlled clinical trials. Transfusion 1996;36:175-186.
13. Colacchio TA, Yeager MP, Hildebrandt LW: Perioperative immunomodulation in cancer surgery. Am J Surg 1994;167:174-179.
14. Meakins JL: Surgeons, surgery, and immunomodulation. Arch Surg 1991;126:494-498.
15. Abo S, Kitamura M, Hashimoto M, et al.: Analysis of results of surgery performed over a 20-year period on 500 patients with cancer of the thoracic esophagus. Surg Today 1996;26:77-82.
16. Imamura M, Shimada Y, Kanda T, et al.: Hemodynamic changes after resection of thoracic duct for en bloc resection of esophageal cancer. Surg Today 1992;22:226-232.
17. Salo M: Effects of anesthesia and surgery on the immune response. Acta Anaesthesiol Scand 1992;36:201-220.
18. Tashiro T. Yamamori H, Takagi K, et al.: Changes in immune function following surgery for esophageal carcinoma. Nutrition 1999;15:760-766.
19. Motoyama S, Kitamura M, Kibira S, et al.: Does central venous pressure reflect circulating blood volume for the decrement of compliance just after esophagectomy? Surg Today 2000;30:11-15.
20. Tashiro T, Yamamori H, Takagi K, et al.: Increased contribution by myofibrillar protein to whole-body protein breakdown according to severity of surgical stress. Nutrition 1996;12:685-689.
21. Tsujinaka T, Kido Y, Ogawa M, et al.: Postoperative hyperbilirubinemia after resection of thoracic esophageal cancer. Am J Gastroenterol 1990;85:1473-1479.
22. Motoyama S, Saito R, Kamata S, et al.: Survival advantage of using autologous blood transfusion during surgery for esophageal cancer. Surg Today 2002;32:951-958.
23. Blajchman MA, Bardossy L, Carmen R, et al.: Allogeneic blood transfusion-induced enhancement of tumor growth: Two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993;81:344-348.
24. Bordin JO, Bardossy L, Blajchman MA: Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: The importance of the timing of the leukodepletion. Blood 1994;84:344-348.
25. Shirwadkar S, Blajchman MA, Frame B, et al.: Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice. J Cancer Res Clin Oncol 1992;118:176-180.
26. Marquet RL, Hoynck van Papendrecht MA, Busch OR, et al.: Blood donation leads to a decrease in natural killer cell activity: A study in normal blood donors and cancer patients. Transfusion 1993;33:368-373.
27. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-1721.
28. Fletcher RH: Treatment. In: Fletcher RH, Fletcher SW, Wagner EH, editors. Clinical epidemiology: The essentials, 3rd edn. Philadelphia: Lippincott Williams & Wilkins; 1996.